Work

Additional Cytotoxic Chemotherapy Is Unlikely to Eliminate Measurable Residual Acute Myeloid Leukemia (AML)

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-131678

Authors: Jacob Appelbaum, Anisha Loeb, Kelda Gardner, Carole M. Shaw, Paul C. Hendrie, Colin D. Godwin, Mary-Elizabeth M. Percival, Anna B. Halpern, Bart L. Scott, Vivian G. Oehler, Roland B. Walter, Pamela S. Becker, Michael C. Jensen, Elihu H. Estey

Institutions: Seattle Cancer Care Alliance, National Institutes of Health, Pitzer College, National Cancer Institute, University of Washington, Fred Hutch Cancer Center, Seattle Children's Research Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2991438486

Cites:

Cited by: 3

Related to: 10